The cookie settings on this website are set to 'allow all cookies' to give you the very best possible experience. If you continue without changing your settings, we will accept your consent. However, if you wish to change your browser settings at anytime go to www.aboutcookies.org for information on how to do this.

To find out more about our Cookies Policy please click here

Rayner Pharmaceuticals

October 3, 2016 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, announced today that it has acquired Moorfields Pharmaceuticals.

The acquisition closed September 30, 2016.

Acquisition details

Rayner has acquired Moorfields Pharmaceuticals from Moorfields Eye Hospital NHS Foundation Trust for an undisclosed price, for the purpose of launching a specialist ophthalmic pharmaceuticals division that will be expanded across Rayner’s direct presence in Europe.

Members of the Moorfields Pharmaceuticals team will transfer to Rayner, however they will continue to be based in London, and will be shortly moving to a new office.

Click here for more information about Rayner Pharmaceuticals.